Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Rosaria Varì is active.

Publication


Featured researches published by Rosaria Varì.


International Journal of Molecular Sciences | 2010

Bioavailability of the Polyphenols: Status and Controversies

Massimo D’Archivio; Carmelina Filesi; Rosaria Varì; Beatrice Scazzocchio; Roberta Masella

The current interest in polyphenols has been driven primarily by epidemiological studies. However, to establish conclusive evidence for the effectiveness of dietary polyphenols in disease prevention, it is useful to better define the bioavailability of the polyphenols, so that their biological activity can be evaluated. The bioavailability appears to differ greatly among the various phenolic compounds, and the most abundant ones in our diet are not necessarily those that have the best bioavailability profile. In the present review, we focus on the factors influencing the bioavailability of the polyphenols. Moreover, a critical overview on the difficulties and the controversies of the studies on the bioavailability is discussed.


Diabetes | 2011

Cyanidin-3- O -β-Glucoside and Protocatechuic Acid Exert Insulin-Like Effects by Upregulating PPARγ Activity in Human Omental Adipocytes

Beatrice Scazzocchio; Rosaria Varì; Carmelina Filesi; Massimo D’Archivio; Carmela Santangelo; Giovannini C; Annunziata Iacovelli; Gianfranco Silecchia; Giovanni Li Volti; Fabio Galvano; Roberta Masella

OBJECTIVE Insulin resistance (IR) represents an independent risk factor for metabolic, cardiovascular, and neoplastic disorders. Preventing/attenuating IR is a major objective to be reached to preserve population health. Because many insulin-sensitizing drugs have shown unwanted side effects, active harmless compounds are sought after. Dietary anthocyanins have been demonstrated to ameliorate hyperglycemia and insulin sensitivity. This study aimed at investigating whether cyanidin-3-O-β-glucoside (C3G) and its metabolite protocatechuic acid (PCA) might have a role in glucose transport activation in human omental adipocytes and 3T3-L1 cells. RESEARCH DESIGN AND METHODS In cells treated with 50 µmol/L C3G and 100 µmol/L PCA, [3H]-2-deoxyglucose uptake, GLUT4 translocation by immunoblotting, adiponectin secretion, and peroxisome proliferator–activated receptor-γ (PPARγ) activation by enzyme-linked immunosorbent assay kits were evaluated. Parallel experiments were carried out in murine adipocyte 3T3-L1. To define the role of PPARγ in modulating polyphenol effects, small interfering RNA technique and PPARγ antagonist were used to inhibit transcription factor activity. RESULTS C3G and PCA increased adipocyte glucose uptake (P < 0.05) and GLUT4 membrane translocation (P < 0.01). Significant increases (P < 0.05) in nuclear PPARγ activity, as well as in adiponectin and GLUT4 expressions (P < 0.01), were also shown. It is interesting that PPARγ inhibition counteracted the polyphenol-induced adiponectin and GLUT4 upregulations, suggesting a direct involvement of PPARγ in this process. CONCLUSIONS Our study provides evidence that C3G and PCA might exert insulin-like activities by PPARγ activation, evidencing a causal relationship between this transcription factor and adiponectin and GLUT4 upregulation. Dietary polyphenols could be included in the preventive/therapeutic armory against pathological conditions associated with IR.


Journal of Nutritional Biochemistry | 2011

Protocatechuic acid induces antioxidant/detoxifying enzyme expression through JNK-mediated Nrf2 activation in murine macrophages

Rosaria Varì; Massimo D'Archivio; Carmelina Filesi; Simona Carotenuto; Beatrice Scazzocchio; Carmela Santangelo; Giovannini C; Roberta Masella

Protocatechuic acid (PCA) is a main metabolite of anthocyanins, whose daily intake is much higher than that of other polyphenols. PCA has biological effects, e.g., it induces the antioxidant/detoxifying enzyme gene expression. This study was aimed at defining the molecular mechanism responsible for PCA-induced over-expression of glutathione (GSH) peroxidase (GPx) and GSH reductase (GR) in J774 A.1 macrophages. New evidence is provided that PCA increases GPx and GR expression by inducing C-JUN NH(2)-terminal kinase (JNK)-mediated phosphorylation of Nuclear factor erythroid 2 (NF-E2)-related factor 2 (Nrf2). RNA and proteins were extracted from cells treated with PCA (25 μM) for different time points. Quantitative real-time polymerase chain reaction and immunoblotting analyses showed a rapid increase in mRNA (>60%) and protein (>50%) for both the enzymes. This was preceded by the up-regulation of Nrf2, in terms of mRNA and protein, and by its significant activation as assessed by increased Nrf2 phosphorylation and nuclear translocation (+60%). By using specific kinase inhibitors and detecting the activated form, we showed that JNK was the main upstream kinase responsible for Nrf2 activation. Convincing evidence is provided of a causal link between PCA-induced Nrf2 activation and increased enzyme expression. By silencing Nrf2 and using a JNK inhibitor, enzyme enhancement was counteracted. Finally, with the ChIP assay, we demonstrated that PCA-activated Nrf2 specifically bound ARE sequences in enzyme gene promoters. Our study demonstrates for the first time that PCA improves the macrophage endogenous antioxidant potential by a mechanism in which JNK-mediated Nrf2 activation plays an essential role. This knowledge could contribute to novel diet-based approaches aimed at counteracting oxidative injury by reinforcing endogenous defences.


Lipids | 2001

Effects of dietary virgin olive oil phenols on low density lipoprotein oxidation in hyperlipidemic patients.

Roberta Masella; Claudio Giovannini; Rosaria Varì; Roberta Di Benedetto; Ettore Coni; Roberto Volpe; Nadia Fraone; A. Bucci

The aim of this study was to assess the effects of the dietary intake of extra virgin olive oil on the oxidative susceptibility of low density lipoproteins (LDL) isolated from the plasma of hyperlipidemic patients. Ten patients with combined hyperlipidemia (mean plasma cholesterol 281 mg/dL, triglycerides 283 mg/dL) consumed a low-fat, low-cholesterol diet, with olive oil (20 g/d) as the only added fat, with no drug or vitamin supplementation for 6 wk. Then they were asked to replace the olive oil they usually consumed with extra virgin olive oil for 4 wk. LDL were isolated at the beginning, and after the 4 wk of dietary treatment. LDL susceptibility to CuSO4-mediated oxidation was evaluated by measuring the extent of lipid peroxidation. We also determined fatty acid composition and vitamin E in plasma and LDL and plasma phenolic content. Extra virgin olive oil intake did not affect fatty acid composition of LDL but significantly reduced the copper-induced formation of LDL hydroperoxides and lipoperoxidation end products as well as the depletion of LDL linoleic and arachidonic acid. A significant increase in the lag phase of conjugated diene formation was observed after dietary treatment. These differences are statistically correlated with the increase in plasma phenolic content observed at the end of the treatment with extra virgin olive oil; they are not correlated with LDL fatty acid composition or vitamin E content, which both remained unmodified after the added fat change. This report suggests that the daily intake of extra virgin olive oil in hyperlipidemic patients could reduce the susceptibility of LDL to oxidation, not only because of its high monounsaturated fatty acid content but probably also because of the antioxidative activity of its phenolic compounds.


FEBS Letters | 2006

Oxidised LDL modulate adipogenesis in 3T3-L1 preadipocytes by affecting the balance between cell proliferation and differentiation

Roberta Masella; Rosaria Varì; Massimo D’Archivio; Carmela Santangelo; Beatrice Scazzocchio; Maria Teresa Maggiorella; Leonardo Sernicola; Fausto Titti; Massimo Sanchez; Umberto Di Mario; Gaetano Leto; Claudio Giovannini

The effects of oxidised LDL (oxLDL) on cell proliferation, apoptosis and hormone‐induced differentiation have been evaluated for the first time in 3T3‐L1 preadipocytes. Unlike control cells, oxLDL‐treated preadipocytes showed a high proliferation rate, a low apoptosis level, and an impaired differentiation process with an increased preadipocyte factor‐1 (Pref‐1) mRNA expression at late times. By silencing Pref‐1 mRNA or inhibiting its expression with an increased dexamethasone concentration, differentiation occurred as usual, which demonstrates the key role of Pref‐1 overexpression. The results suggest a specific action of oxLDL on the adipogenesis inhibitor Pref‐1, as indicated also by its reappearance in mature adipocytes treated with oxLDL. The inhibitory effects of oxLDL on differentiation required oxLDL uptake by CD36, and were associated with lipoprotein lipids. These results point to oxLDL as a modulator of adipose tissue mass and as possible link between obesity and its clinical complications.


European Journal of Clinical Investigation | 2012

Predominant role of obesity/insulin resistance in oxidative stress development

Massimo D’Archivio; Giovanni Annuzzi; Rosaria Varì; Carmelina Filesi; Rosalba Giacco; Beatrice Scazzocchio; Carmela Santangelo; Giovannini C; Angela A. Rivellese; Roberta Masella

Eur J Clin Invest 2012; 42 (1): 70–78


FEBS Letters | 2008

Oxidised LDL up-regulate CD36 expression by the Nrf2 pathway in 3T3-L1 preadipocytes

Massimo D'Archivio; Beatrice Scazzocchio; Carmela Filesi; Rosaria Varì; Maria Teresa Maggiorella; Leonardo Sernicola; Carmela Santangelo; Claudio Giovannini; Roberta Masella

The effect of oxLDL on CD36 expression has been assessed in preadipocytes induced to differentiate. Novel evidence is provided that oxLDL induce a peroxisome proliferator‐activated receptor γ‐independent CD36 overexpression, by up‐regulating nuclear factor erythroid 2 (NF‐E2)‐related factor 2 (Nrf2). The nuclear translocation of Nrf2 appeared to depend on PKC pathway activation. In adipocytes, the CD36 up‐regulation may indicate a compensation mechanism to meet the demand of excess oxLDL and oxidised lipids in blood, reducing the risk of atherogenesis. Besides strengthening the hypothesis that oxLDL can contribute to the onset of insulin‐resistance, data herein presented highlight the significance of oxLDL‐induced CD36 overexpression within the cellular defence response.


Immunology | 2001

Redox imbalance and immune functions: opposite effects of oxidized low‐density lipoproteins and N‐acetylcysteine

Marina Viora; Maria Giovanna Quaranta; Elisabetta Straface; Rosaria Varì; Roberta Masella; Walter Malorni

This study investigates the in vitro effects of oxidized low‐density lipoproteins (ox‐LDL), ‘physiological’ pro‐oxidants, N‐acetylcysteine (NAC), a free radical scavenger and glutathione precursor, and their combination on human peripheral blood mononuclear cell functions. We found that treatment with ox‐LDL induced a significant down‐regulation of proliferative response to mitogens, antigens and interleukin‐2. Lipid extracts from ox‐LDL were able to reproduce the same effect as the lipoprotein. On the other hand, NAC exposure induced a significant up‐regulation of proliferative responses to all the stimuli used. Moreover, we showed that natural killer (NK) cell‐mediated cytotoxic activity was significantly down‐regulated by ox‐LDL while treatment with NAC induced a significant up‐regulation of NK‐cell activity. Finally, we found that ox‐LDL and NAC exerted opposite effects on the cytokine network, interfering both at the protein secretion level and the messenger RNA synthesis level. More importantly, when NAC was used in combination with ox‐LDL the proliferative responses, NK‐cell‐mediated cytotoxic activity and cytokine production were restored to values comparable to controls. These data indicate that ox‐LDL and NAC modulate immune functions, exerting opposite effects reflecting their pro‐oxidant and antioxidant behaviours. Our results add new insights to the key role played by redox imbalance as a modulator of immune system homeostasis and suggest that an antioxidant drug such as NAC could be useful against pathologies associated with an increase in lipid peroxidation.


Journal of Lipid Research | 2009

Oxidized LDL impair adipocyte response to insulin by activating serine/threonine kinases

Beatrice Scazzocchio; Rosaria Varì; Massimo D'Archivio; Carmela Santangelo; Carmelina Filesi; Giovannini C; Roberta Masella

Oxidized LDL (oxLDL) increase in patients affected by type-2 diabetes, obesity, and metabolic syndrome. Likewise, insulin resistance, an impaired responsiveness of target tissues to insulin, is associated with those pathological conditions. To investigate a possible causal relationship between oxLDL and the onset of insulin resistance, we evaluated the response to insulin of 3T3-L1 adipocytes treated with oxLDL. We observed that oxLDL inhibited glucose uptake (−40%) through reduced glucose transporter 4 (GLUT4) recruitment to the plasma membrane (−70%), without affecting GLUT4 gene expression. These findings were associated to the impairment of insulin signaling. Specifically, in oxLDL-treated cells insulin receptor (IR) substrate-1 (IRS-1) was highly degraded likely because of the enhanced Ser307phosphorylation. This process was largely mediated by the activation of the inhibitor of κB-kinase β (IKKβ) and the c-Jun NH2-terminal kinase (JNK). Moreover, the activation of IKKβ positively regulated the nuclear content of nuclear factor κB (NF-κB), by inactivating the inhibitor of NF-κB (IκBα). The activated NF-κB further impaired per se GLUT4 functionality. Specific inhibitors of IKKβ, JNK, and NF-κB restored insulin sensitivity in adipocytes treated with oxLDL. These data provide the first evidence that oxLDL, by activating serine/threonine kinases, impaired adipocyte response to insulin affecting pathways involved in the recruitment of GLUT4 to plasma membranes (PM). This suggests that oxLDL might participate in the development of insulin resistance.


Molecular Nutrition & Food Research | 2015

Protocatechuic acid activates key components of insulin signaling pathway mimicking insulin activity

Beatrice Scazzocchio; Rosaria Varì; Carmelina Filesi; Ilaria Del Gaudio; Massimo D'Archivio; Carmela Santangelo; Annunziata Iacovelli; Fabio Galvano; Francesca Romana Pluchinotta; Claudio Giovannini; Roberta Masella

SCOPE Insulin resistance represents an independent risk factor for metabolic and cardiovascular diseases. Researchers have been interested in identifying active harmless compounds, as many insulin-sensitizing drugs have shown unwanted side-effects. It has been demonstrated that anthocyanins and one of their representative metabolites, protocatechuic acid (PCA), ameliorate hyperglycemia, and insulin sensitivity. This study investigated the mechanism of action of PCA responsible for the glucose uptake upregulation. METHODS AND RESULTS In human visceral adipocytes, PCA stimulated insulin receptor substrate-1 (IRS-1) tyrosine phosphorylation (+40% with respect to untreated cells) and the downstream events, i.e. phosphoinositide 3-kinase binding to IRS-1 and Akt phosphorylation (+100%, +180%, respectively, with respect to untreated cells). The insulin-like activity of PCA seemed to be mediated by insulin receptor since by inhibiting its autophosphorylation, the PCA effects were completely abolished. Furthermore, PCA was able to activate adenosine monophosphate-activated protein kinase, a serine/threonine kinase whose activation elicits insulin-sensitizing effects. CONCLUSION This study showed that PCA stimulates the insulin signaling pathway in human adipocytes increasing GLUT4 translocation and glucose uptake. Decreasing insulin resistance is a most desirable aim to be reached for an effective therapeutic/preventive action against metabolic syndrome and type 2 diabetes. Identifying specific food/food components able to improve glucose metabolism can offer an attractive, novel, and economical strategy.

Collaboration


Dive into the Rosaria Varì's collaboration.

Top Co-Authors

Avatar

Roberta Masella

Istituto Superiore di Sanità

View shared research outputs
Top Co-Authors

Avatar

Beatrice Scazzocchio

Istituto Superiore di Sanità

View shared research outputs
Top Co-Authors

Avatar

Carmela Santangelo

Istituto Superiore di Sanità

View shared research outputs
Top Co-Authors

Avatar

Claudio Giovannini

Istituto Superiore di Sanità

View shared research outputs
Top Co-Authors

Avatar

Massimo D'Archivio

Istituto Superiore di Sanità

View shared research outputs
Top Co-Authors

Avatar

Giovannini C

Sapienza University of Rome

View shared research outputs
Top Co-Authors

Avatar

Carmelina Filesi

Istituto Superiore di Sanità

View shared research outputs
Top Co-Authors

Avatar

Massimo D’Archivio

Istituto Superiore di Sanità

View shared research outputs
Top Co-Authors

Avatar

Carmela Filesi

Istituto Superiore di Sanità

View shared research outputs
Top Co-Authors

Avatar

Roberta Di Benedetto

Istituto Superiore di Sanità

View shared research outputs
Researchain Logo
Decentralizing Knowledge